HPC Biosciences Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
409.85 Cr.
|
P/BV
|
12.48
|
Book Value (Rs.)
|
2.06
|
52 Week High/Low (Rs.)
|
26/26
|
FV/ML
|
1/3000
|
P/E(X)
|
350.82
|
Bookclosure
|
24/09/2023
|
EPS (Rs.)
|
0.07
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 0.07 | 0.02 | 0.03 | 0.01 | 0.03 |
Diluted EPS (Rs.) | 0.07 | 0.02 | 0.03 | 0.01 | 0.03 |
Cash EPS (Rs.) | 0.10 | 0.05 | 0.07 | 0.06 | 0.09 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 2.06 | 1.99 | 1.96 | 1.93 | 1.92 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 2.06 | 1.99 | 1.96 | 1.93 | 1.92 |
Revenue From Operations / Share (Rs.) | 0.14 | 0.07 | 0.10 | 0.12 | 0.14 |
PBDIT / Share (Rs.) | 0.10 | 0.06 | 0.08 | 0.06 | 0.09 |
PBIT / Share (Rs.) | 0.07 | 0.02 | 0.03 | 0.01 | 0.03 |
PBT / Share (Rs.) | 0.07 | 0.02 | 0.03 | 0.01 | 0.03 |
Net Profit / Share (Rs.) | 0.07 | 0.02 | 0.03 | 0.01 | 0.03 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 74.54 | 80.73 | 80.81 | 55.19 | 68.93 |
PBIT Margin (%) | 52.12 | 29.92 | 36.07 | 11.90 | 25.03 |
PBT Margin (%) | 52.12 | 29.92 | 36.07 | 11.90 | 25.03 |
Net Profit Margin (%) | 51.16 | 28.06 | 34.63 | 10.12 | 22.48 |
Return on Networth / Equity (%) | 3.56 | 1.06 | 1.76 | 0.63 | 1.65 |
Return on Capital Employeed (%) | 3.62 | 1.13 | 1.84 | 0.75 | 1.84 |
Return On Assets (%) | 3.53 | 1.04 | 1.73 | 0.62 | 1.63 |
Asset Turnover Ratio (%) | 0.07 | 0.03 | 0.05 | 0.06 | 0.07 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 92.99 | 53.95 | 42.49 | 47.41 | 52.59 |
Quick Ratio (X) | 91.04 | 52.19 | 40.91 | 45.45 | 49.55 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 413.86 | 413.87 | 501.68 | 647.12 | 774.78 |
EV / Net Operating Revenue (X) | 181.05 | 344.99 | 313.51 | 332.72 | 343.10 |
EV / EBITDA (X) | 242.86 | 427.30 | 387.93 | 602.85 | 497.73 |
MarketCap / Net Operating Revenue (X) | 181.18 | 345.24 | 313.67 | 332.75 | 343.14 |
Price / BV (X) | 12.61 | 13.07 | 16.01 | 21.02 | 25.33 |
Price / Net Operating Revenue (X) | 181.22 | 345.54 | 313.87 | 332.92 | 343.35 |